Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Compound PH-894 Targeting BRD4 Protein
PH-894 protection for chemical structure, genetic sequencing and broad application for proliferative and infectious diseases in U.S. Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, August 13, 2026 /EINPresswire.com…